SA PRO
Free Account
KalVista Pharmaceuticals, Inc.KALVNASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 9, 2026H.C. Wainwright
KalVista price target raised to $37 from $27 at H.C. Wainwright
Target:$37.00
+133.9%from $15.82
Jan 6, 2026Needham
KalVista price target raised to $32 from $28 at Needham
Target:$32.00
+104.3%from $15.66
Nov 11, 2025JMP Securities
KalVista price target lowered to $28 from $29 at Citizens JMP
Target:$28.00
+157.1%from $10.89
Nov 5, 2024Needham
Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $28 at Needham
Target:$28.00
+148.9%from $11.25
Sep 6, 2024H.C. Wainwright
H.C. Wainwright Reiterates Buy Rating on Kalvista Pharmaceuticals Inc (KALV)
Target:$20.00
+55.4%from $12.87
Sep 6, 2024Leerink Partners
Leerink Partners Reiterates Outperform Rating on Kalvista Pharmaceuticals Inc (KALV)
Target:$20.00
+55.4%from $12.87
Jul 8, 2022Needham
Needham Maintains Buy on KalVista Pharmaceuticals, Lowers Price Target to $38
Target:$38.00
+246.1%from $10.98

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance